A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety

Psychiatry Research - Neuroimaging

Volumn 146, Issue 2, 2006, Pages 137-147

  Whiteside, Stephen P ^a   Port, John D ^a   Deacon, Brett J ^b   Abramowitz, Jonathan S ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF WYOMING   (United States)

Author keywords

Anxiety; Caudate; Magnetic resonance spectroscopy; Neuroimaging; Obsessive compulsive disorder; Orbitofrontal white matter

Indexed keywords

CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ANXIETY; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; HUMAN; HUMAN TISSUE; MEDICAL RESEARCH; METHODOLOGY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADULT; ANXIETY DISORDERS; BRAIN; CAUDATE NUCLEUS; DEPRESSION; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PREFRONTAL CORTEX; SEVERITY OF ILLNESS INDEX;

EID: 33646478267     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2005.12.006     Document Type: Article

References (32)

1. 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. American Journal of Psychiatry 155 (1998) 1584-1591
2. Baxter Jr. L.R., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., Alazraki A., Selin C.E., Ferng H.K., Munford P., et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. American Journal of Psychiatry 49 9 (1992) 1560-1563
3. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 4 (1961) 561-571
4. Beck A.T., Steer R.A., and Garbin M.G. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clinical Psychology Review 8 (1988) 77-100
5. Cottraux J., Gerard D., Cinotti L., Froment J.C., Deiber M.P., Le Bars D., Galy G., Millet P., Labbé C., Lavenne F., Bouvard M., and Mauguière F. A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals. Psychiatry Research: Neuroimaging 60 (1996) 101-112
6. Courvoisie H., Hooper S.R., Fine C., Kwock L., and Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. Journal of Neuropsychiatry and Clinical Neurosciences 16 (2004) 63-69
7. Davanzo P., Thomas M.A., Yue K., Oshiro T., Belin T., Strober M., and McCracken J. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology 24 (2001) 359-369
8. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Research: Neuroimaging 74 (1997) 173-176
9. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B., 1996. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2. New York State Psychiatric Institute, Biometrics Research, New York.
10. Fitzgerald K.D., Moore G.J., Paulson L.A., Stewart C.M., and Rosenberg D.R. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. (comment). Biological Psychiatry 47 (2000) 174-182
11. Foa E.B., Huppert J.D., Leiberg S., Langner R., Kichic R., Hajcak G., and Salkovskis P.M. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychological Assessment 14 (2002) 485-496
12. Frances A., Docherty J.P., and Kahn D.A. Treatment of obsessive-compulsive disorder. Journal of Clinical Psychiatry 58 (1997) 5-72
13. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Delgado P., Heninger G.R., and Charney D.S. The Yale-Brown Obsessive Compulsive Scale: II. Validity. Archives of General Psychiatry 46 (1989) 1012-1016
14. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleishmann R.L., Hill C.L., Heninger G.R., and Charney D.S. The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Archives of General Psychiatry 46 (1989) 1006-1011
15. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23 (1960) 56-62
16. Lucey J.V., Costa D.C., Blanes T., Busatto G.F., Pilowsky L.S., Takei N., Marks I.M., Ell P.J., and Kerwin R.W. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions. British Journal of Psychiatry 167 (1995) 629-634
17. 99mTcHMPAO single photon emission tomography (SPET). British Journal of Psychiatry 171 (1997) 346-350
18. Ohara K., Isoda H., Suzuki Y., Takehara Y., Ochiai M., Takeda H., and Igarashi Y. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder. Psychiatry Research: Neuroimaging 92 (1999) 83-91
19. 1H magnetic resonance spectroscopy in patients with epilepsy. Journal of Cerebral Blood Flow and Metabolism 20 (2000) 871-878
20. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine 30 (1993) 672-679
21. Rauch S.L. Neuroimaging research and the neurobiology of obsessive-compulsive disorder: where do we go from here?. (comment). Biological Psychiatry 47 (2000) 168-170
22. Rosenberg D.R., and Keshavan M.S. A.E. Bennett Research Award. Toward a neurodevelopmental model of obsessive-compulsive disorder. Biological Psychiatry 43 (1998) 623-640
23. Rosenberg D.R., MacMaster F.P., Keshavan M.S., Fitzgerald K.D., Stewart C.M., and Moore G.J. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. Journal of the American Academy of Child and Adolescent Psychiatry 39 (2000) 1096-1103
24. Rosenberg D.R., Amponsah A., Sullivan A., MacMillan S., and Moore G.J. Increased medial thalamic choline in pediatric obsessive-compulsive disorder as detected by quantitative in vivo spectroscopic imaging. Journal of Child Neurology 16 (2001) 636-641
25. Rosenberg D.R., Mirza Y., Russell A., Tang J., Smith J.M., Banerjee S.P., Bhandari R., Rose M., Ivey J., Boyd C., and Moore G.J. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. Journal of the American Academy of Child and Adolescent Psychiatry 43 (2004) 1146-1153
26. Russell A., Cortese B., Lorch E., Ivey J., Banerjee S.P., Moore G.J., and Rosenberg D.R. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology 13 Suppl 1 (2003) S31-S38
27. Saxena S., Bota R.G., and Brody A.L. Brain-behavior relationships in obsessive-compulsive disorder. Seminars in Clinical Neuropsychiatry 6 (2001) 82-101
28. Smith E.A., Russell A., Lorch E., Banerjee S.P., Rose M., Ivey J., Bhandari R., Moore G.J., and Rosenberg D.R. Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biological Psychiatry 54 (2003) 1399-1405
29. Spielberger C.D., Gorsuch R.L., Lushene R.E., Vagg P.R., and Jacobs G.A. Revised Manual for the State-Trait Anxiety Inventory (1983), Consulting Psychologists Press, Palo Alto, CA
30. Steingard R.J., Yurgelun-Todd D.A., Hennen J., Moore J.C., Moore C.M., Vakili K., Young A.D., Katic A., Beardslee W.R., and Renshaw P.F. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biological Psychiatry 48 (2000) 1053-1061
31. Taylor S. The assessment of obsessions and compulsions: reliability, validity and sensitivity to treatment effects. Clinical Psychology Review 15 (1995) 261-296
32. Whiteside S.P., Port J.D., and Abramowitz J.S. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Research: Neuroimaging 132 (2004) 69-79